SKAN Group AG Stock price

Equities

SKAN

CH0013396012

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 11:30:41 2023-12-08 am EST Intraday chart for SKAN Group AG 5-day change 1st Jan Change
80 CHF +0.50% +2.30% +26.98%
Sales 2023 * 326M 370M Sales 2024 * 388M 441M Capitalization 1.8B 2.04B
Net income 2023 * 30M 34.08M Net income 2024 * 41M 46.58M EV / Sales 2023 *
5,19x
Net cash position 2023 * 110M 125M Net cash position 2024 * 109M 124M EV / Sales 2024 *
4,36x
P/E ratio 2023 *
58,7x
P/E ratio 2024 *
43,6x
Employees 1,269
Yield 2023 *
0,55%
Yield 2024 *
0,73%
Free-Float 46.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.50%
1 week+2.30%
Current month+0.38%
1 month+10.50%
3 months+1.65%
6 months+4.85%
Current year+26.98%
More quotes
1 week
76.80
Extreme 76.8
80.70
1 month
71.00
Extreme 71
81.50
Current year
62.70
Extreme 62.7
88.60
1 year
62.70
Extreme 62.7
88.60
3 years
13.10
Extreme 13.1
95.19
5 years
7.90
Extreme 7.9
95.19
10 years
5.50
Extreme 5.5
95.19
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 2008
Director of Finance/CFO 41 2017
Chief Operating Officer 51 2021
Members of the board TitleAgeSince
Director/Board Member 61 2021
Director/Board Member 46 2021
Chief Executive Officer 57 2008
More insiders
Date Price Change Volume
23-12-08 80 +0.50% 9,973
23-12-07 79.6 -0.25% 6,920
23-12-06 79.8 +0.25% 19,281
23-12-05 79.6 +1.66% 8,572
23-12-04 78.3 +0.13% 4,039

Delayed Quote Swiss Exchange, December 08, 2023 at 11:30 am EST

More quotes
SKAN Group AG, former BV Holding AG, is a Switzerland-based holding company of an equity investment group, engaged in the participation in enterprises in Switzerland. It concentrates on companies from the industry, micro and medical technology, processing and material technology, information technology and related services. Target enterprises are those being in special situations, such as management buy-out and buy-in, changes in shareholders’ structure, succession financing, as well as coming through growth or expansion phase. The Company acts as an entrepreneurial partner in the long term. Operational activities are delegated to the independent advisor BV Partners AG. BV Holding AG and BV Partners AG form the BVgroup. As of December 31, 2011, its investment portfolio included nine companies: Covalys BioSciences AG, E2E Technologies Ltd., Lonstroff Holding AG, Piexon AG, POLYDATA AG, SKAN Holding AG, Sphinx Werkzeuge AG, Ypsomed Holding AG and Ziemer Group AG.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
80CHF
Average target price
91.33CHF
Spread / Average Target
+14.17%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock SKAN Group AG - Swiss Exchange
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer